Goldman Sachs’s NEOPHOTONICS CORP NPTN Stock Holding History

Goldman Sachs’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-361,300	Closed	-$3.19M	–	5661
2019 Q4	$3.19M	Buy	+361,300	New	+$2.7M	﹤0.01%	3305
2018 Q2	–	Sell	-230,000	Closed	-$1.58M	–	6136
2018 Q1	$1.58M	Buy	+230,000	New	+$1.46M	﹤0.01%	3749
2015 Q3	–	Sell	-51,200	Closed	-$467K	–	7553
2015 Q2	$467K	Buy	+51,200	New	+$388K	﹤0.01%	5278

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Goldman Sachs's NPTN Position: Q3 2022 in Review

Goldman Sachs sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 1,689,218 shares — an estimated $26.6M sold.

Goldman Sachs first reported a position in NPTN in Q3 2013 and held it in 36 quarters. The position peaked at $26.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Goldman Sachs reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 1,689,218 NEOPHOTONICS CORP shares in Q3 2022, an estimated $26.6M.
Goldman Sachs first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 36 quarters.
Goldman Sachs's NEOPHOTONICS CORP position peaked at $26.6M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.